Mitigation of chromosome loss in clinical CRISPR-Cas9-engineered T cells
Cell,
CRISPR-Cas9 genome editing induces persistent chromosome loss in human primary T cells and engineered CAR T cells for clinical…
CRISPR-Cas9 genome editing induces persistent chromosome loss in human primary T cells and engineered CAR T cells for clinical…
CRISPR-based cancer dependency maps are accelerating advances in cancer precision medicine, but adequate functional maps are…